Home » Russia Private Equity »


|| Russian RBV Capital has acquired stake in US medtech company for $80 million

RBV Capital, a venture capital based in Russia, has acquired stake in Pipeline Therapeutics, a US-based medical technology company for $80 million.

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases. The company's therapies leverage the natural repair process in several different nervous system cell types to target diseases such as multiple sclerosis, providing patients with a treatment to repair damage to the nervous system.

(Founded in 2014, RBV Capital is a venture fund based in Moscow, Russia with a partnership office in Wilen, Switzerland. The company focuses on pharmaceuticals, biologics, digital healthcare products, and medical devices.)



Previous Post: Russian investment firm invested $10 million in Indian ed-tech firm Classplus
Next Post: Russian investment firm HashCIB has acquired stake in US blockchain startup for $4.3 million



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2021     RussiaBeat.com

Follow us: RSS Feed  |   Twitter